Guidelines for the treatment and management of new-onset diabetes after transplantation.


Although graft and patient survival after solid organ transplantation have improved markedly in recent years, transplant recipients continue to experience an increased prevalence of cardiovascular disease (CVD) compared with the general population. A number of factors are known to impact on the increased risk of CVD in this population, including… (More)


4 Figures and Tables

Cite this paper

@article{Wilkinson2005GuidelinesFT, title={Guidelines for the treatment and management of new-onset diabetes after transplantation.}, author={Alan H Wilkinson and Jaime A. Davidson and Francesco Dotta and Philip D Home and Paul Keown and Bryce A. Kiberd and Alan George Mackenzie Jardine and Naomi Levitt and Piero Marchetti and Mariana S Markell and Sarala Naicker and P. R. O'Connell and Mark A. Schnitzler and Eberhard Standl and Jose-Vicente Torregosa and Kazuharu Uchida and Hannah A. Valantine and Federico Guillermo Villamil and Flavio G Vincenti and Martin Wissing}, journal={Clinical transplantation}, year={2005}, volume={19 3}, pages={291-8} }